Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer (NY: PFE ) 28.90 +0.12 (+0.42%) Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pfizer < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Want $2,000 in Annual Dividends? Invest $30,000 in These 3 High-Yielding Stocks August 24, 2024 Before interest rates come down, you may want to consider loading up on these terrific income stocks. Via The Motley Fool Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets August 23, 2024 Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,... Via Benzinga FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot August 22, 2024 The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to... Via Benzinga Exposures COVID-19 Product Safety Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine August 22, 2024 From Pfizer Inc. Via Business Wire Pfizer's Options Frenzy: What You Need to Know August 21, 2024 Via Benzinga Is Pfizer Stock Ready to Bounce Back? August 18, 2024 The stock won't stay down forever. Via The Motley Fool These 3 Stocks Pay You More Than 5% to Own Them August 22, 2024 High dividend yields paired with fundamentally sound and undervalued stocks provide opportunities for both income and long-term capital appreciation. Via MarketBeat Mr. Darren Walker, Dr. Albert Bourla, and Secretary General Jens Stoltenberg to be awarded Concordia Leadership Award at the 2024 Annual Summit this September August 22, 2024 NEW YORK, N.Y., Aug. 22, 2024 (SEND2PRESS NEWSWIRE) -- The Concordia Leadership Council is proud to announce the recipients of the 2024 Leadership Award: Mr. Darren Walker, President of the Ford... Via Send2Press Value Investing: Unearthing 3 Hidden Gems in Today's Market August 21, 2024 Discover undervalued companies and build long-term wealth through the insightful strategy of value investing. Via MarketBeat Pfizer, Conagra Brands And 2 Other Stocks Insiders Are Selling August 15, 2024 Via Benzinga Merck's Stock Dip Offers a Buying Opportunity: Here’s Why August 20, 2024 Global big pharmaceutical company Merck & Co. Inc. (NYSE: MRK) shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates, Via MarketBeat Topics Intellectual Property Exposures Intellectual Property 2 Cheap Passive Income Stocks to Buy Now August 20, 2024 Passive income stocks offer potential for steady returns and financial security in retirement. Via The Motley Fool 3 Top Value Stocks to Buy Right Now August 20, 2024 Value stocks offer potential for significant returns in today's overheated market. Via The Motley Fool Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? August 19, 2024 Its 12-month relative strength performance is impressive, but Novavax now faces resistance. Via Investor's Business Daily FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch August 19, 2024 The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak. Via Benzinga Topics ETFs Exposures COVID-19 Product Safety Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze? August 19, 2024 Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release. Via MarketBeat Exposures COVID-19 Product Safety Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell? August 19, 2024 A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19. Via The Motley Fool 3 Dividend Stocks to Double Up On Right Now August 17, 2024 How does a 5.7% dividend yield sound? Via The Motley Fool Prediction: These Could Be the Best-Performing Value Stocks Through 2030 August 17, 2024 These cheap stocks might not be cheap for too much longer. Via The Motley Fool Why Pfizer Stock Slumped on Friday August 16, 2024 Investors were cautiously pessimistic about the latest news coming out of the company's lab. Via The Motley Fool Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark August 16, 2024 The company is now considering whether it needs to change up the vaccine to pass muster. Via Investor's Business Daily Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study August 16, 2024 Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of two primary immunogenicity objectives. Adjustments are planned to improve... Via Benzinga Exposures COVID-19 Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk August 16, 2024 A Florida State Court sided with GSK, dismissing expert testimonies that linked ranitidine to prostate cancer, reflecting a broader scientific consensus that there is no consistent evidence supporting... Via Benzinga Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age August 16, 2024 From Pfizer Inc. Via Business Wire Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters August 14, 2024 On Thursday, Eli Lilly and Company (NYSE: LLY) reported its second quarter results, smashing estimates fueled by the popularity of its blockbuster diabetes drug Mounjaro and weight loss injection... Via Benzinga 7 Dependable Dividend Stocks for Long-Term Income August 14, 2024 Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets. Via InvestorPlace 3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct August 14, 2024 These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth. Via InvestorPlace 3 Top Investing Opportunities During Stock Market Chaos August 13, 2024 These stocks look like some of the top investing opportunities to buy on the recent dip that has the broader investment class worried. Via InvestorPlace 7 Divine Dividend Stocks to Buy for Another Market Crash August 13, 2024 Dividend stocks have proved remarkably resilient even during severe market downturns, making them perfect additions to your portfolio. Via InvestorPlace Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows August 13, 2024 COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 9 ... 99 100 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.